| Lastest Insider Transactions Of Candel Therapeutics, Inc. ( CADL ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| CADL | Candel Therapeutics, Inc. | Barone Francesca | Chief Scientific Officer | 2025-01-15 | Sell | 13,534 | 7.22 | 97,783 | 2025-01-17 16:30:08 |
| CADL | Candel Therapeutics, Inc. | Tyagarajan Seshu | Chief Technology Officer | 2025-01-15 | Sell | 14,322 | 7.22 | 103,476 | 2025-01-17 16:30:07 |
| CADL | Candel Therapeutics, Inc. | Schoch Charles | See Remarks | 2025-01-15 | Sell | 9,511 | 7.22 | 68,717 | 2025-01-17 16:30:06 |
| CADL | Candel Therapeutics, Inc. | Barone Francesca | Chief Scientific Officer | 2025-01-08 | Sell | 13,673 | 8.22 | 112,367 | 2025-01-10 16:30:11 |
| CADL | Candel Therapeutics, Inc. | Schoch Charles | See Remarks | 2025-01-08 | Sell | 9,971 | 8.22 | 81,944 | 2025-01-10 16:30:09 |
| CADL | Candel Therapeutics, Inc. | Tak Paul Peter | Chief Executive Officer | 2025-01-08 | Sell | 21,172 | 8.22 | 173,996 | 2025-01-10 16:30:08 |
| CADL | Candel Therapeutics, Inc. | Tyagarajan Seshu | Chief Technology Officer | 2025-01-08 | Sell | 14,545 | 8.22 | 119,534 | 2025-01-10 16:30:06 |
| CADL | Candel Therapeutics, Inc. | Nichols William Garrett | Chief Medical Officer | 2025-01-08 | Sell | 10,799 | 8.22 | 88,749 | 2025-01-10 16:30:03 |
| CADL | Candel Therapeutics, Inc. | Manning Paul B | Directior | 2024-12-16 | Buy | 1,250,000 | 6.00 | 7,500,000 | 2024-12-18 16:11:47 |
| CADL | Candel Therapeutics, Inc. | Tyagarajan Seshu | Chief Technology Officer | 2024-11-29 | Sell | 20,392 | 4.56 | 92,898 | 2024-12-03 17:48:39 |
| CADL | Candel Therapeutics, Inc. | Tak Paul Peter | Chief Executive Officer | 2024-11-29 | Sell | 48,847 | 4.56 | 222,527 | 2024-12-03 17:48:05 |
| CADL | Candel Therapeutics, Inc. | Nichols William Garrett | Chief Medical Officer | 2024-11-29 | Sell | 13,935 | 4.56 | 63,482 | 2024-12-03 17:47:24 |
| CADL | Candel Therapeutics, Inc. | Barone Francesca | Chief Scientific Officer | 2024-11-29 | Sell | 22,081 | 4.56 | 100,592 | 2024-12-03 17:46:34 |
| CADL | Candel Therapeutics, Inc. | Tak Paul Peter | Chief Executive Officer | 2024-11-21 | Option Exercise | 12,900 | 1.55 | 19,995 | 2024-11-21 15:07:23 |
| CADL | Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo | 10% Owner | 2024-10-11 | Sell | 40,412 | 6.03 | 243,834 | 2024-10-15 17:59:40 |
| CADL | Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo | 10% Owner | 2024-10-01 | Sell | 35,002 | 6.93 | 242,642 | 2024-10-03 18:19:19 |
| CADL | Candel Therapeutics, Inc. | Tyagarajan Seshu | Chief Technology Officer | 2024-07-17 | Sell | 14,851 | 6.47 | 96,125 | 2024-07-19 08:31:07 |
| CADL | Candel Therapeutics, Inc. | Tak Paul Peter | Chief Executive Officer | 2024-07-17 | Sell | 22,528 | 6.47 | 145,815 | 2024-07-19 08:29:42 |
| CADL | Candel Therapeutics, Inc. | Schoch Charles | See Remarks | 2024-07-17 | Sell | 9,884 | 6.47 | 63,975 | 2024-07-19 08:28:33 |
| CADL | Candel Therapeutics, Inc. | Nichols William Garrett | Chief Medical Officer | 2024-07-17 | Sell | 10,875 | 6.47 | 70,390 | 2024-07-19 08:26:47 |
| CADL | Candel Therapeutics, Inc. | Barone Francesca | Chief Scientific Officer | 2024-07-17 | Sell | 14,051 | 6.47 | 90,947 | 2024-07-19 08:24:58 |
| CADL | Candel Therapeutics, Inc. | Tyagarajan Seshu | Chief Technology Officer | 2024-07-11 | Sell | 13,330 | 5.97 | 79,625 | 2024-07-15 08:36:43 |
| CADL | Candel Therapeutics, Inc. | Tak Paul Peter | Chief Executive Officer | 2024-07-11 | Sell | 20,293 | 5.97 | 121,218 | 2024-07-15 08:35:22 |
| CADL | Candel Therapeutics, Inc. | Schoch Charles | See Remarks | 2024-07-11 | Sell | 8,897 | 5.97 | 53,145 | 2024-07-15 08:34:13 |
| CADL | Candel Therapeutics, Inc. | Nichols William Garrett | Chief Medical Officer | 2024-07-11 | Sell | 9,769 | 5.97 | 58,354 | 2024-07-15 08:32:33 |
| CADL | Candel Therapeutics, Inc. | Barone Francesca | Chief Scientific Officer | 2024-07-11 | Sell | 12,645 | 5.97 | 75,534 | 2024-07-15 08:30:56 |
| CADL | Candel Therapeutics, Inc. | Martell Christopher | Directior | 2022-12-08 | Buy | 27,000 | 1.89 | 51,108 | 2023-02-17 18:40:24 |
| CADL | Candel Therapeutics, Inc. | Barone Francesca | Chief Scientific Officer | 2022-12-08 | Buy | 1,238 | 1.61 | 1,993 | 2022-12-12 16:30:29 |
| CADL | Candel Therapeutics, Inc. | PAPA JOSEPH C | Directior | 2022-12-08 | Buy | 38,032 | 1.92 | 73,059 | 2022-12-12 16:25:33 |
| CADL | Candel Therapeutics, Inc. | Martell Christopher | Directior | 2022-12-08 | Buy | 27,000 | 1.89 | 51,108 | 2022-12-12 16:25:27 |
| CADL | Candel Therapeutics, Inc. | Tak Paul Peter | Chief Executive Officer | 2022-12-08 | Buy | 15,985 | 1.88 | 30,020 | 2022-12-12 16:25:25 |
| CADL | Candel Therapeutics, Inc. | Tyagarajan Seshu | Chief Technology Officer | 2022-12-08 | Buy | 13,358 | 1.88 | 25,061 | 2022-12-12 16:25:21 |
| CADL | Candel Therapeutics, Inc. | Amello Jason | Chief Financial Officer | 2022-12-08 | Buy | 5,568 | 1.80 | 10,002 | 2022-12-12 16:25:17 |
